Interferon gamma blocks the growth of Toxoplasma gondii in human fibroblasts by inducing the host cells to degrade tryptophan (original) (raw)

Abstract

Treatment of human fibroblasts with human recombinant gamma interferon blocked the growth of Toxoplasma gondii, an obligate intracellular protozoan parasite. Growth of the parasite was measured by a plaque assay 7 days after infection or by the incorporation of [3H]uracil 1 or 2 days after infection. The antitoxoplasma activity induced in the host cells by gamma interferon was strongly dependent upon the tryptophan concentration of the medium. Progressively higher minimal inhibitory concentrations of gamma interferon were observed as the tryptophan concentration in the culture medium was increased. Treatment with gamma interferon did not make the cells impermeable to tryptophan. The kinetics of [3H]tryptophan uptake into the acid-soluble pools of control and gamma interferon-treated cultures were identical during the first 48 sec. Thereafter uptake of [3H]tryptophan into the acid-soluble pool of control fibroblasts reached the expected plateau after 96 sec. In contrast, uptake of [3H]tryptophan continued for at least 12 min in the gamma interferon-treated cultures. At that time, the acid-soluble pool of the gamma interferon-treated cultures contained 8 times the radioactivity of the control cultures. This continued accumulation was the result of rapid intracellular degradation of [3H]tryptophan into kynurenine and N-formylkynurenine that leaked slowly from the cells. These two metabolites were also recovered from the medium of cultures treated for 1 or 2 days with gamma interferon. Human recombinant alpha and beta interferons, which have no antitoxoplasma activity, did not induce any detectable degradation of tryptophan. Several hypotheses are presented to explain how the intracellular degradation of tryptophan induced by gamma interferon could restrict the growth of an obligate intracellular parasite.

908

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aikawa M., Komata Y., Asai T., Midorikawa O. Transmission and scanning electron microscopy of host cell entry by Toxoplasma gondii. Am J Pathol. 1977 May;87(2):285–296. [PMC free article] [PubMed] [Google Scholar]
  2. Anderson S. E., Jr, Remington J. S. Effect of normal and activated human macrophages on Toxoplasma gondii. J Exp Med. 1974 May 1;139(5):1154–1174. doi: 10.1084/jem.139.5.1154. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Baglioni C., Maroney P. A. Mechanisms of action of human interferons. Induction of 2'5'-oligo(A) polymerase. J Biol Chem. 1980 Sep 25;255(18):8390–8393. [PubMed] [Google Scholar]
  4. Burke D. C. The mechanism of interferon production. Philos Trans R Soc Lond B Biol Sci. 1982 Sep 24;299(1094):51–57. doi: 10.1098/rstb.1982.0105. [DOI] [PubMed] [Google Scholar]
  5. Colonno R. J., Pang R. H. Induction of unique mRNAs by human interferons. J Biol Chem. 1982 Aug 25;257(16):9234–9237. [PubMed] [Google Scholar]
  6. DULBECCO R., FREEMAN G. Plaque production by the polyoma virus. Virology. 1959 Jul;8(3):396–397. doi: 10.1016/0042-6822(59)90043-1. [DOI] [PubMed] [Google Scholar]
  7. EAGLE H. Nutrition needs of mammalian cells in tissue culture. Science. 1955 Sep 16;122(3168):501–514. doi: 10.1126/science.122.3168.501. [DOI] [PubMed] [Google Scholar]
  8. Gray P. W., Leung D. W., Pennica D., Yelverton E., Najarian R., Simonsen C. C., Derynck R., Sherwood P. J., Wallace D. M., Berger S. L. Expression of human immune interferon cDNA in E. coli and monkey cells. Nature. 1982 Feb 11;295(5849):503–508. doi: 10.1038/295503a0. [DOI] [PubMed] [Google Scholar]
  9. Hovanessian A. G., Meurs E., Aujean O., Vaquero C., Stefanos S., Falcoff E. Antiviral response and induction of specific proteins in cells treated with immune T (type II) interferon analogous to that from viral interferon (type I)-treated cells. Virology. 1980 Jul 15;104(1):195–204. doi: 10.1016/0042-6822(80)90377-3. [DOI] [PubMed] [Google Scholar]
  10. Kerr I. M., Cayley P. J., Silverman R. H., Knight M. The antiviral action of interferon. Philos Trans R Soc Lond B Biol Sci. 1982 Sep 24;299(1094):59–67. doi: 10.1098/rstb.1982.0106. [DOI] [PubMed] [Google Scholar]
  11. MEHLER A. H., KNOX W. E. The conversion of tryptophan to kynurenine in liver. II. The enzymatic hydrolysis of formylkynurenine. J Biol Chem. 1950 Nov;187(1):431–438. [PubMed] [Google Scholar]
  12. Pfefferkorn E. R., Pfefferkorn L. C. Toxoplasma gondii: isolation and preliminary characterization of temperature-sensitive mutants. Exp Parasitol. 1976 Jun;39(3):365–376. doi: 10.1016/0014-4894(76)90040-0. [DOI] [PubMed] [Google Scholar]
  13. Pfefferkorn E. R. Toxoplasma gondii: the enzymic defect of a mutant resistant to 5-fluorodeoxyuridine. Exp Parasitol. 1978 Feb;44(1):26–35. doi: 10.1016/0014-4894(78)90077-2. [DOI] [PubMed] [Google Scholar]
  14. Remington J. S., Merigan T. C. Interferon: protection of cells infected with an intracellular protozoan (Toxoplasma gondii). Science. 1968 Aug 23;161(3843):804–806. doi: 10.1126/science.161.3843.804. [DOI] [PubMed] [Google Scholar]
  15. Schmunis G., Weissenbacher M., Chowchuvech E., Sawicki L., Galin M. A., Baron S. Growth of Toxoplasma gondii in various tissue cultures treated with In-Cn or interferon. Proc Soc Exp Biol Med. 1973 Sep;143(4):1153–1157. doi: 10.3181/00379727-143-37490. [DOI] [PubMed] [Google Scholar]
  16. Shirahata T., Shimizu K. Production and properties of immune interferon from spleen cell cultures of Toxoplasma-infected mice. Microbiol Immunol. 1980;24(11):1109–1120. doi: 10.1111/j.1348-0421.1980.tb02915.x. [DOI] [PubMed] [Google Scholar]
  17. Verhaegen-Lewalle M., Kuwata T., Zhang Z. X., DeClercq E., Cantell K., Content J. 2-5A synthetase activity induced by interferon alpha, beta, and gamma in human cell lines differing in their sensitivity to the anticellular and antiviral activities of these interferons. Virology. 1982 Mar;117(2):425–434. doi: 10.1016/0042-6822(82)90481-0. [DOI] [PubMed] [Google Scholar]
  18. Vilcek J., Jahiel R. I. Action of interferon and its inducers aginst nonviral infectious agents. Arch Intern Med. 1970 Jul;126(1):69–77. doi: 10.1001/archinte.126.1.69. [DOI] [PubMed] [Google Scholar]
  19. Weil J., Epstein C. J., Epstein L. B., Sedmak J. J., Sabran J. L., Grossberg S. E. A unique set of polypeptides is induced by gamma interferon in addition to those induced in common with alpha and beta interferons. Nature. 1983 Feb 3;301(5899):437–439. doi: 10.1038/301437a0. [DOI] [PubMed] [Google Scholar]
  20. Yoshida R., Imanishi J., Oku T., Kishida T., Hayaishi O. Induction of pulmonary indoleamine 2,3-dioxygenase by interferon. Proc Natl Acad Sci U S A. 1981 Jan;78(1):129–132. doi: 10.1073/pnas.78.1.129. [DOI] [PMC free article] [PubMed] [Google Scholar]